135 related articles for article (PubMed ID: 12052062)
1. Evaluation of infection parameters in the production of replication-defective HSV-1 viral vectors.
Ozuer A; Wechuck JB; Russell B; Wolfe D; Goins WF; Glorioso JC; Ataai MM
Biotechnol Prog; 2002; 18(3):476-82. PubMed ID: 12052062
[TBL] [Abstract][Full Text] [Related]
2. Engineering cell lines for production of replication defective HSV-1 gene therapy vectors.
Grant KG; Krisky DM; Ataai MM; Glorioso JC
Biotechnol Bioeng; 2009 Mar; 102(4):1087-97. PubMed ID: 18828174
[TBL] [Abstract][Full Text] [Related]
3. Combined HSV-1 recombinant and amplicon piggyback vectors: replication-competent and defective forms, and therapeutic efficacy for experimental gliomas.
Pechan PA; Herrlinger U; Aghi M; Jacobs A; Breakefield XO
J Gene Med; 1999; 1(3):176-85. PubMed ID: 10738566
[TBL] [Abstract][Full Text] [Related]
4. Long-term persistence of defective HSV-1 vectors in the rat brain is demonstrated by reactivation of vector gene expression.
Starr PA; Lim F; Grant FD; Trask L; Lang P; Yu L; Geller AI
Gene Ther; 1996 Jul; 3(7):615-23. PubMed ID: 8818649
[TBL] [Abstract][Full Text] [Related]
5. Deletion of multiple immediate-early genes from herpes simplex virus reduces cytotoxicity and permits long-term gene expression in neurons.
Krisky DM; Wolfe D; Goins WF; Marconi PC; Ramakrishnan R; Mata M; Rouse RJ; Fink DJ; Glorioso JC
Gene Ther; 1998 Dec; 5(12):1593-603. PubMed ID: 10023438
[TBL] [Abstract][Full Text] [Related]
6. [Expression of foreign genes in adult rats' central nervous system by use of defective herpes simplex virus type 1 vectors].
Yang T; Wang X; Yan Z; Hou Y
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1997 Dec; 11(4):306-10. PubMed ID: 15617234
[TBL] [Abstract][Full Text] [Related]
7. Effect of protease inhibitors on yield of HSV-1-based viral vectors.
Wechuck JB; Goins WF; Glorioso JC; Ataai MM
Biotechnol Prog; 2000; 16(3):493-6. PubMed ID: 10835254
[TBL] [Abstract][Full Text] [Related]
8. Construction and production of recombinant herpes simplex virus vectors.
Goins WF; Krisky DM; Wechuck JB; Huang S; Glorioso JC
Methods Mol Biol; 2008; 433():97-113. PubMed ID: 18679619
[TBL] [Abstract][Full Text] [Related]
9. Latency associated promoter transgene expression in the central nervous system after stereotaxic delivery of replication-defective HSV-1-based vectors.
Scarpini CG; May J; Lachmann RH; Preston CM; Dunnett SB; Torres EM; Efstathiou S
Gene Ther; 2001 Jul; 8(14):1057-71. PubMed ID: 11526453
[TBL] [Abstract][Full Text] [Related]
10. Multiple immediate-early gene-deficient herpes simplex virus vectors allowing efficient gene delivery to neurons in culture and widespread gene delivery to the central nervous system in vivo.
Lilley CE; Groutsi F; Han Z; Palmer JA; Anderson PN; Latchman DS; Coffin RS
J Virol; 2001 May; 75(9):4343-56. PubMed ID: 11287583
[TBL] [Abstract][Full Text] [Related]
11. Properties of a herpes simplex virus multiple immediate-early gene-deleted recombinant as a vaccine vector.
Watanabe D; Brockman MA; Ndung'u T; Mathews L; Lucas WT; Murphy CG; Felber BK; Pavlakis GN; Deluca NA; Knipe DM
Virology; 2007 Jan; 357(2):186-98. PubMed ID: 16996101
[TBL] [Abstract][Full Text] [Related]
12. Gene transfer into hepatocytes mediated by herpes simplex virus-Epstein-Barr virus hybrid amplicons.
Müller L; Saydam O; Saeki Y; Heid I; Fraefel C
J Virol Methods; 2005 Jan; 123(1):65-72. PubMed ID: 15582700
[TBL] [Abstract][Full Text] [Related]
13. Multiple applications for replication-defective herpes simplex virus vectors.
Burton EA; Wechuck JB; Wendell SK; Goins WF; Fink DJ; Glorioso JC
Stem Cells; 2001; 19(5):358-77. PubMed ID: 11553845
[TBL] [Abstract][Full Text] [Related]
14. Optimal purification method for Herpes-based viral vectors that confers minimal cytotoxicity for systemic route of vector administration.
Sia KC; Wang GY; Ho IA; Khor HY; Miao L; Hui KM; Lam PY
J Virol Methods; 2007 Feb; 139(2):166-74. PubMed ID: 17074404
[TBL] [Abstract][Full Text] [Related]
15. Comparative analysis of genomic HSV vectors for gene delivery to motor neurons following peripheral inoculation in vivo.
Perez MC; Hunt SP; Coffin RS; Palmer JA
Gene Ther; 2004 Jul; 11(13):1023-32. PubMed ID: 15164091
[TBL] [Abstract][Full Text] [Related]
16. Highly efficient regulation of gene expression by tetracycline in a replication-defective herpes simplex viral vector.
Yao F; Theopold C; Hoeller D; Bleiziffer O; Lu Z
Mol Ther; 2006 Jun; 13(6):1133-41. PubMed ID: 16574491
[TBL] [Abstract][Full Text] [Related]
17. Herpes simplex virus vectors for gene transfer to the nervous system.
Goins WF; Krisky D; Marconi P; Oligino T; Ramakrishnan R; Poliani PL; Fink DJ; Glorioso JC
J Neurovirol; 1997 May; 3 Suppl 1():S80-8. PubMed ID: 9179803
[TBL] [Abstract][Full Text] [Related]
18. Identification of a replication-defective herpes simplex virus for recombinant adeno-associated virus type 2 (rAAV2) particle assembly using stable producer cell lines.
Toublanc E; Benraiss A; Bonnin D; Blouin V; Brument N; Cartier N; Epstein AL; Moullier P; Salvetti A
J Gene Med; 2004 May; 6(5):555-64. PubMed ID: 15133766
[TBL] [Abstract][Full Text] [Related]
19. Triple gene-deleted oncolytic herpes simplex virus vector double-armed with interleukin 18 and soluble B7-1 constructed by bacterial artificial chromosome-mediated system.
Fukuhara H; Ino Y; Kuroda T; Martuza RL; Todo T
Cancer Res; 2005 Dec; 65(23):10663-8. PubMed ID: 16322208
[TBL] [Abstract][Full Text] [Related]
20. Development of herpes simplex virus replication-defective multigene vectors for combination gene therapy applications.
Krisky DM; Marconi PC; Oligino TJ; Rouse RJ; Fink DJ; Cohen JB; Watkins SC; Glorioso JC
Gene Ther; 1998 Nov; 5(11):1517-30. PubMed ID: 9930305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]